Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ROH-201 Ophthalmic Solution Phase IIb Trial in Dry Eye Disease
jRCT2031220368Phase 2Completed
- Sponsor
- Rohto Pharmaceutical Co., Ltd.
- Start
- Oct 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in dry eye syndrome (DED) comparing ROH-201 ophthalmic solution with Placebo ophthalmic solution (2 arms). Started Oct 2022; status: completed.
02
Drugs
delgocitinib
03
Conditions
dry eye syndrome (DED)
Beyond the preview
Go deeper on jRCT2031220368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031220368.